Share Twitter LinkedIn Facebook Email Speaking from the 2018 Genitourinary Cancers Symposium in San Francisco, CA, Peter Black, MD, of the University of British Columbia, Vancouver, CA, outlines the development of systemic therapy for non-muscle invasive bladder cancer. Advertisement
FDA Approves INLEXZOโข / Gemcitabine Intravesical: A Breakthrough for Bladder Cancer Treatment Bladder 4 Mins Read
FDA Approves New Bladder Cancer Therapy: A Look at Anktiva Nogapendekin Alfa Inbakicept-pmln Bladder 4 Mins Read